Botanix Pharmaceuticals Ltd
ASX:BOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dong Suh Companies Inc
KRX:026960
|
KR |
|
R
|
RENK Group AG
XETRA:R3NK
|
DE |
|
Q
|
Qingdao TGOOD Electric Co Ltd
SZSE:300001
|
CN |
|
N
|
Nam Mu Hydropower JSC
VN:HJS
|
VN |
|
B
|
BAE Systems PLC
SWB:BSP
|
UK |
|
K
|
Korea Electronic Certification Authority Inc
KOSDAQ:041460
|
KR |
|
M
|
Mennica Polska SA
WSE:MNC
|
PL |
|
CSSC Offshore & Marine Engineering Group Co Ltd
SSE:600685
|
CN |
|
Proximus NV
XBRU:PROX
|
BE |
|
A
|
Anzheng Fashion Group Co Ltd
SSE:603839
|
CN |
|
T
|
Turbine Aviation Inc
OTC:TURA
|
US |
|
P
|
Paragon Union Bhd
KLSE:PGLOBE
|
MY |
|
A
|
Adra Gayrimenkul Yatirim Ortakligi AS
IST:ADGYO.E
|
TR |
Botanix Pharmaceuticals Ltd
Other
Botanix Pharmaceuticals Ltd
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Other
-AU$5.7m
|
CAGR 3-Years
-90%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-30%
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Other
AU$3.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Other
-AU$37k
|
CAGR 3-Years
-164%
|
CAGR 5-Years
49%
|
CAGR 10-Years
-12%
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Other
-AU$193.4k
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vita Life Sciences Ltd
ASX:VLS
|
Other
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nyrada Inc
ASX:NYR
|
Other
-AU$407.1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
Glance View
Botanix Pharmaceuticals Ltd. engages in the development of therapeutics for the treatment of skin diseases. The company is headquartered in Perth, Western Australia. The firm's product pipelines are based on drug delivery technology known as Permetrex. Its product pipeline consists of three clinical programs, which are using synthetic cannabidiol in the topical treatment of serious skin diseases and for antimicrobial applications. Its product pipeline includes BTX 1503 Gel, BTX 1702 Solution and BTX 1801 Ointment. Its BTX1503 Gel is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. Its BTX 1702 Solution is used for the treatment of papulopustular rosacea. Its BTX 1801 Ointment is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA). The firm also has a chemistry program to identify, synthesize and test chemical entities that are related to naturally occurring cannabinoids.
See Also
What is Botanix Pharmaceuticals Ltd's Other?
Other
-5.7m
AUD
Based on the financial report for Dec 31, 2025, Botanix Pharmaceuticals Ltd's Other amounts to -5.7m AUD.
What is Botanix Pharmaceuticals Ltd's Other growth rate?
Other CAGR 10Y
-30%
Over the last year, the Other growth was -36%. The average annual Other growth rates for Botanix Pharmaceuticals Ltd have been -90% over the past three years , and -30% over the past ten years .
